Avatrombopag is an effective and safe second-line treatment for adult patients with chronic immune thrombocytopenia (ITP). In addition, this thrombopoietin receptor agonist can be used in adults with chronic liver disease prior to invasive surgery to prevent bleeding events. For both indications, treatment should be initiated and supervised by a physician experienced with hematologic disorders.